Degeneracy, mimicry and crossreactivity in immune recognition.

M. Cohn

DOI: https://doi.org/10.1016/J.MOLIMM.2004.09.010

IF: 4.174

2005-03-01

Molecular Immunology

Abstract:

What problem does this paper attempt to address?

Cementum status in natural teeth opposing implant-borne bridgework in Macaca fascicularis.

C. Siar,C. K. Pua,C. G. Toh,G. Romanos,K. Ng

DOI: https://doi.org/10.1016/j.tripleo.2011.07.049

2012-11-01

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Abstract:
[CME-ORL. Cystic metastasis of a squamous epithelial carcinoma stage III on the right].

Michael Schlumpf,J. Jakscha,C. Storck

DOI: https://doi.org/10.1024/1661-8157/a001895

2015-01-14

Praxis

Abstract:
Physiology- or Imaging-Guided Strategies for Intermediate Coronary Stenosis.

Seokhun Yang,Jeehoon Kang,Doyeon Hwang,Jinlong Zhang,Jun Jiang,Xinyang Hu,Joo-Yong Hahn,Chang-Wook Nam,Joon-Hyung Doh,Bong-Ki Lee,Weon Kim,Jinyu Huang,Fan Jiang,Hao Zhou,Peng Chen,Lijiang Tang,Wenbing Jiang,Xiaomin Chen,Wenming He,Sung Gyun Ahn,Myeong-Ho Yoon,Ung Kim,Joo Myung Lee,You-Jeong Ki,Eun-Seok Shin,Hyo-Soo Kim,Seung-Jea Tahk,Jian'an Wang,Bon-Kwon Koo

DOI: https://doi.org/10.1001/jamanetworkopen.2023.50036

2024-01-01

JAMA Network Open

Abstract:Importance: Treatment strategies for intermediate coronary lesions guided by fractional flow reserve (FFR) and intravascular ultrasonography (IVUS) have shown comparable outcomes. Identifying low-risk deferred vessels to ensure the safe deferral of percutaneous coronary intervention (PCI) and high-risk revascularized vessels that necessitate thorough follow-up can help determine optimal treatment strategies.Objectives: To investigate outcomes according to treatment types and FFR and IVUS parameters after FFR- or IVUS-guided treatment.Design, setting, and participants: This cohort study included patients with intermediate coronary stenosis from the Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in Patients With Intermediate Stenosis (FLAVOUR) trial, an investigator-initiated, prospective, open-label, multicenter randomized clinical trial that assigned patients into an IVUS-guided strategy (which recommended PCI for minimum lumen area [MLA] <= 3 mm2 or 3 mm2 to 4 mm2 with plaque burden [PB] >= 70%) or an FFR-guided strategy (which recommended PCI for FFR <= 0.80). Data were analyzed from November to December 2022.Exposures: FFR or IVUS parameters within the deferred and revascularized vessels.Main outcomes and measures: The primary outcome was target vessel failure (TVF), a composite of cardiac death, target vessel myocardial infarction, and revascularization at 2 years.Results: A total of 1619 patients (mean [SD] age, 65.1 [9.6] years; 1137 [70.2%] male) with 1753 vessels were included in analysis. In 950 vessels for which revascularization was deferred, incidence of TVF was comparable between IVUS and FFR groups (3.8% vs 4.1%; P = .72). Vessels with FFR greater than 0.92 in the FFR group and MLA greater than 4.5 mm2 or PB of 58% or less in the IVUS group were identified as low-risk deferred vessels, with a decreased risk of TVF (hazard ratio [HR], 0.25 [95% CI, 0.09-0.71]; P = .009). In 803 revascularized vessels, the incidence of TVF was comparable between IVUS and FFR groups (3.6% vs 3.7%; P = .95), which was similar in the revascularized vessels undergoing PCI optimization (4.2% vs 2.5%; P = .31). Vessels with post-PCI FFR of 0.80 or less in the FFR group or minimum stent area of 6.0 mm2 or less or with PB at stent edge greater than 58% in the IVUS group had an increased risk for TVF (HR, 7.20 [95% CI, 3.20-16.21]; P < .001).Conclusions and relevance: In this cohort study of patients with intermediate coronary stenosis, FFR- and IVUS-guided strategies showed comparable outcomes in both deferred and revascularized vessels. Binary FFR and IVUS parameters could further define low-risk deferred vessels and high-risk revascularized vessels.
Validation of the Global Anatomic Staging System (GLASS) Using the BASIL-1 Best Endovascular Therapy Cohort

Akio Kodama,Lewis Meecham,Matthew Popplewell,Gareth Bate,Andrew Bradbury

DOI: https://doi.org/10.1016/j.ejvs.2018.08.015

IF: 6.427

2018-01-01

European Journal of Vascular and Endovascular Surgery

Abstract:Background: Endovascular treatment of post-thrombotic syndrome using nitinol venous stents is associated with symptomatic improvement, but w40% require re-intervention.We examined whether ultrasound surveillance was sensitive for re-intervention, and whether it was possible to predict patients at greatest risk of re-intervention.Methods: Stent patency was assessed between 2012e2017 using duplex ultrasonography 24hrs, 2wks, 6wks, 3mths, 6mths, 1yr and yearly post-intervention.Maximum in-stent stenosis was calculated, with re-interventions performed when stent diameter reduction was >50%.Patient demographics were collected to determine which factors were associated with re-intervention.Results: Cumulative patency was 167/194 (86%).However, 79 (41%) patients required re-intervention to maintain patency, of which 40/79 (51%) occurred within 3wks of their procedure.Stenting across the inguinal ligament was associated with a higher risk of early re-intervention (HR 1.817; p¼0.048, 95% CI [1.005e 3.285]).Re-interventions immediately followed surveillance in 70/ 79 (87%) cases, and this was driven by scan results rather than symptom change.At 6wks, maximum in-stent stenosis <30% was a strong predictor of being low risk for re-intervention at 6mths (HR 0.038; p¼0.003, 95% CI [0.004-0.322]).Conversely, maximum in-stent stenosis between 30-50% at 6wks was associated with a higher risk of re-intervention at 6mths (HR 29.90; p¼0.002, 95% CI [3.519e253.989]).Conclusions: Ultrasound surveillance should occur at frequent intervals up to 3wks post deep venous stenting.Surveillance at 6wks could be used to differentiate between patients that require further surveillance before 6mths.These may include patients with maximum in-stent stenosis between 30-50% at 6wks and patients with stents crossing the inguinal ligament.
Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor*

K. Takayama,G. Garcı́a-Cardeña,G. Sukhova,J. Comander,M. Gimbrone,P. Libby

DOI: https://doi.org/10.1074/JBC.M204810200

IF: 5.485

2002-11-15

Journal of Biological Chemistry

Abstract:Pro-inflammatory pathways participate in the pathogenesis of atherosclerosis. However, the role of endogenous anti-inflammatory pathways in atheroma has received much less attention. Therefore, using cDNA microarrays, we screened for genes regulated by prostaglandin E2 (PGE2), a potential endogenous anti-inflammatory mediator, in lipopolysaccharide (LPS)-treated human macrophages (MΦ). PGE2 (50 nm) attenuated LPS-induced mRNA and protein expression of chemokines including monocyte chemoattractant protein-1, interleukin-8, macrophage inflammatory protein-1α and -1β, and interferon-inducible protein-10. PGE2 also inhibited the tumor necrosis factor-α-, interferon-γ-, and interleukin-1β-mediated expression of these chemokines. In contrast to the case of MΦ, PGE2 did not suppress chemokine expression in human endothelial and smooth muscle cells (SMC) treated with LPS and pro-inflammatory cytokines. To assess the potential paracrine effect of endogenous PGE2 on macrophage-derived chemokine production, we co-cultured MΦ with SMC in the presence of LPS. In these co-cultures, cyclooxygenase-2-dependent PGE2 production exceeded that in the mono-cultures, and MIP-1β declined significantly compared with MΦ cultured without SMC. We further documented prominent expression of the PGE2receptor EP4 in MΦ in both culture and human atheroma. Moreover, a selective EP4 antagonist completely reversed PGE2-mediated suppression of chemokine production. Thus, endogenous PGE2may modulate inflammation during atherogenesis and other inflammatory diseases by suppressing macrophage-derived chemokine production via the EP4 receptor.
In-Stent Restenosis Progression in Human Superficial Femoral Arteries: Dynamics of Lumen Remodeling and Impact of Local Hemodynamics

Monika Colombo,Yong He,Anna Corti,Diego Gallo,Federica Ninno,Stefano Casarin,Jared M Rozowsky,Francesco Migliavacca,Scott Berceli,Claudio Chiastra

DOI: https://doi.org/10.1007/s10439-021-02776-1

IF: 3.8

2021-04-29

Annals of Biomedical Engineering

Abstract:Abstract In-stent restenosis (ISR) represents a major drawback of stented superficial femoral arteries (SFAs). Motivated by the high incidence and limited knowledge of ISR onset and development in human SFAs, this study aims to (i) analyze the lumen remodeling trajectory over 1-year follow-up period in human stented SFAs and (ii) investigate the impact of altered hemodynamics on ISR initiation and progression. Ten SFA lesions were reconstructed at four follow-ups from computed tomography to quantify the lumen area change occurring within 1-year post-intervention. Patient-specific computational fluid dynamics simulations were performed at each follow-up to relate wall shear stress (WSS) based descriptors with lumen remodeling. The largest lumen remodeling was found in the first post-operative month, with slight regional-specific differences (larger inward remodeling in the fringe segments, p < 0.05). Focal re-narrowing frequently occurred after 6 months. Slight differences in the lumen area change emerged between long and short stents, and between segments upstream and downstream from stent overlapping portions, at specific time intervals. Abnormal patterns of multidirectional WSS were associated with lumen remodeling within 1-year post-intervention. This longitudinal study gave important insights into the dynamics of ISR and the impact of hemodynamics on ISR progression in human SFAs.

engineering, biomedical
Natural history of superior mesenteric artery in-stent restenosis

Ahmed A Sorour,Hassan Dehaini,Khaled I Alnahhal,Ali Khalifeh,Jarrad W Rowse,Jon G Quatromoni,Francis J Caputo,Sean P Lyden,Lee Kirksey

DOI: https://doi.org/10.1016/j.jvs.2023.11.035

Abstract:Objective: Superior mesenteric artery (SMA) stenting is the preferred approach for patients with symptomatic SMA-associated chronic mesenteric ischemia (CMI). The durability of this modality is impacted by in-stent restenosis (ISR). Duplex ultrasound (DUS) and computed tomographic angiography (CTA)-measured ISR may be weakly correlated and not uniformly associated with recurrence of presenting symptoms. This study aims to analyze the association between the degree of ISR for patients with CMI and to develop a predictive model for symptom recurrence. Methods: Single center, retrospective study included all patients with CMI with SMA stents from the period of 2003 to 2020. Follow-up period analysis included patients' symptoms recurrence, DUS, CTA, and angiography. A receiver operating characteristic (ROC) analysis was used to evaluate whether peak systolic velocity (PSV) was predictive of symptom recurrence. A subgroup analysis of patients (asymptomatic and symptomatic) with SMA ISR was identified; restenosis defined by DUS with peak systolic velocity (PSV) ≥350. Results: The study included 186 patients with the ROC analysis obtained from 503 postoperative visits. PSV was not a predictor of symptoms return with area under the curve (AUC) = 0.49 (95% confidence interval [CI], 0.40-0.57). Agreement analysis between imaging modalities showed higher agreement between CTA and angiogram (AUC, 0.769; 95% CI, 0.688-0.849) vs CTA and DUS (AUC, 0.650; 95% CI, 0.589-0.711). The subgroup analysis of patients with ISR included 99 patients (asymptomatic n = 67; symptomatic n = 32). There was no statistical difference between median time (months) to ISR between both groups: 4.5 (asymptomatic group) and 7.6 (symptomatic group). The use of preoperative antiplatelet (86% vs 65%; P = .015) and P2Y12 receptor blockers (36% vs 13%; P = .016) was more prevalent in the asymptomatic group. There was no difference between the type or number of stents placed, stent diameter, or concomitant celiac artery intervention between both groups. Conclusions: The natural history of SMA and multimodality defined ISR in CMI has not previously been described. Elevated PSV was a poor predictor of symptoms recurrence. Both asymptomatic and symptomatic patients with ISR did not differ in type of stent placed, time to ISR, or involvement of celiac artery. Antiplatelet use pre- and postoperatively appears protective against symptoms recurrence. Our findings underscore the need for long-term surveillance integrating clinical evaluation and multimodality imaging when indicated.
Society for Vascular Surgery duplex ultrasound surveillance guidelines are safe and cost effective for transcarotid artery revascularization

Richard Li,Abdur Jamal,Sharon Chao,Tessabella Magliochetti Cammarata,Brian R Beeman

DOI: https://doi.org/10.1016/j.jvs.2023.05.038

Abstract:Background: Carotid duplex ultrasound (CDUS) examination is used in the long-term surveillance after transcarotid artery revascularization (TCAR). The objective of this study was to evaluate the usefulness and cost effectiveness of post-TCAR CDUS surveillance regimens in monitoring for in-stent restenosis (ISR) and associated stroke risk at a single-center community institution. Methods: CDUS data were collected retrospectively from patients who had undergone TCAR between January 2017 and January 2023. ISR >50% was defined as a peak systolic velocity (PSV) of >220 cm/s and an internal carotid artery (ICA) to common carotid velocity ratio of >2.7. ISR >80% was defined as a PSV of >340 cm/s and an ICA/common carotid artery ratio of >4.15. Study outcomes included incidences of ISR, reintervention, transient ischemic attacks (TIAs), strokes, and mortality. A Kaplan-Meier survival analysis was done to calculate the rates of freedom from ISR. Results: During the study period, 108 TCAR stents were deployed in 104 patients. Eight patients were excluded in analysis or lost to follow-up. Preoperatively, 62% of patients had >80% stenosis, and 39% were symptomatic. No intraprocedural complications were noted. One patient suffered an immediate postoperative dissection. Eight stents (8%) experienced ISR progression from <50% to >50%. Three of the eight had further ISR progression to >80%. One patient had high-grade ISR and a contralateral ICA occlusion that warranted reintervention. There were no occurrences of postoperative TIAs, strokes, or TCAR-related deaths. Rates of freedom from ISR progression from <50% to >50% were 97.4%, 95.9%, 90.9%, 88.2%, and 88.2% at 6, 12, 24, 36, and 42 months, respectively. Rates of freedom from ISR >80% were 100%, 100%, 98.5%, 95.5%, and 95.5% at the same time points. Patients with >50% ISR tended to be females with hyperlipidemia. In addition, they had higher average lesion lengths and lower rates of postdilation balloon angioplasty. The 5-year estimated surveillance cost in this cohort using the Society for Vascular Surgery 2022, and 2018 guidelines, as well as our current protocol would be $113,853, $221,382, and $193,207, respectively. Conclusions: This study revealed a low incidence of ISR progression, as well as no TIA, stroke, or TCAR-related deaths, highlighting the safety and efficacy of TCAR. Post-TCAR CDUS examination using the updated Society for Vascular Surgery guidelines are safe and cost effective. Patients with contralateral occlusion or stenosis, or who have significant risk factors, should have more frequent surveillance regimens.
Oncogenic effect of repeated inoculation of mice with sheep erythrocytes.

R. Tyndall,J. A. Otten,P. Estes

DOI: https://doi.org/10.1097/00007890-197208000-00021

1972-08-01

Transplantation

Abstract:
Factors Influencing the Outcome of Symptomatic Intracranial Artery Stenosis With Hemodynamic Impairment After Short and Long-Term Stent Placement

Wentao Gong,Xianjun Zhang,Zhen Meng,Feifei Liu,Guangwen Li,Juan Xiao,Peng Liu,Yujie Sun,Tonghui Liu,Hongxia Wang,Yong Zhang,Naidong Wang

DOI: https://doi.org/10.3389/fneur.2022.682694

IF: 3.4

2022-05-18

Frontiers in Neurology

Abstract:Objective: Stent placement is a feasible approach worldwidely for patients with symptomatic intracranial artery stenosis (sICAS) and hemodynamic impairment (HI) who are at high risk of recurrent stroke after medical treatment. Exploration of factors associated with poor outcomes after stent placement could help develop better individualized therapeutic strategies. Methods: This study conducted a post-hoc analysis of a prospective, multicenter registry study of stent use for sICAS with HI in China. Patient and clinical demographics, and stenotic lesion images were analyzed using univariate and multivariate Cox regression to the time until any endpoints or the end of the follow-up period. The short-term endpoint included any transient ischemic attack (TIA), stroke, or death within 1 month after stent placement. The long-term endpoints included the short-term endpoints and any TIA or stroke in the region of the affected artery that occurred more than 1 month after stent placement. Results: Two hundred and ninety two patients were included, with 13 short-term and 39 long-term endpoints. Multivariate Cox regression analysis revealed that lesions at the arterial origin or bifurcation (Hazard Ratio (HR) = 7.52; 95% CI, 1.89–29.82; p = 0.004) were significantly associated with higher short-term risk. Baseline renal insufficiency reduced the risk (HR = 0.08; 95% CI: 0.01–0.68; p = 0.021). Factors significantly associated with higher long-term risk included irregular or ulcerated plaques at the lesion (HR = 2.15; 95% CI: 1.07–4.33; p = 0.031). Subgroup analyses indicated that higher risk occurred in the older age group (age>59 years, HR = 3.73, 95% CI: 1.27–10.97, p = 0.017), and not in the younger group (age≤59 years, HR = 1.12, 95% CI: 0.42–3.03, p = 0.822). Conclusion: Irregular or ulcerated plaques in older patients and lesions at the arterial opening or bifurcation were more likely to result in adverse endpoints for stent placement during long or short -term follow-up. Investigation of these factors might facilitate the development of individualized therapeutic strategies for this population. Clinical Trial Registration: http://www.clinicaltrials.gov, identifier: NCT01968122.

neurosciences,clinical neurology
Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study)

P de Jaegere,H Mudra,H Figulla,Y Almagor,S Doucet,I Penn,A Colombo,C Hamm,A Bartorelli,M Rothman,M Nobuyoshi,T Yamaguchi,V Voudris,C DiMario,S Makovski,D Hausmann,S Rowe,S Rabinovich,M Sunamura,G A van Es

DOI: https://doi.org/10.1053/euhj.1998.1012

Abstract:Objectives: A study was set up to validate the safety and feasibility of intravascular ultrasound-guided stenting without subsequent anticoagulation, and its impact on the 6 months restenosis rate. Methods: The study was designed to be multicentred, prospective, and observational. Results: One hundred and sixty-one patients with stable angina and a de novo coronary artery lesion were enrolled. In four patients, the implantation of a Palmaz-Schatz (with spiral bridge) stent had failed. One of these four patients died 3 days following bypass surgery. In two other patients, intravascular ultrasound assessment was not performed. One hundred and twenty-five of the remaining 155 patients (81%) were treated with aspirin (100 mg x day(-1)), because all three criteria for optimized stent expansion were met. Twenty-two of the remaining 38 patients (25%), in whom at least one criterion was not met were treated with aspirin and acenocoumarol (3 months, INR 2.5-3.5), while 16 patients only received aspirin. Stent thrombosis was documented in two patients (1.3%) for which repeat angioplasty was performed. During the hospital stay, there were no deaths or Q-wave myocardial infarctions. Five patients (3.2%) sustained a non-Q-wave myocardial infarction. During the follow-up period (198+/-38 days, complete for all patients, except one), one patient (0.6%) sustained a Q-wave myocardial infarction, one (0.6%) underwent bypass surgery, and repeat angioplasty was performed in nine patients (5.7%). In two of the nine patients, repeat angioplasty involved another lesion. Therefore, the target lesion revascularization rate during follow-up was 4.5% (seven patients). At quantitative coronary angiography, the minimal lumen diameter (mean+/-SD) increased from 1.12+/-0.34 mm before to 2.89+/-0.35 mm after stenting. Repeat angiography at 6 months was performed in 144 patients (92%). The minimal lumen diameter at follow-up was 2.12+/-0.67 mm. Restenosis (diameter stenosis of 50% or more) was documented in 12 patients or 8.3%. When the two patients with documented stent thrombosis are included, the restenosis rate amounts to 97%. Conclusions: These data confirm that, in selected patients, stents can safely be implanted without the use of systemic anticoagulation, provided optimal stent expansion is achieved. The exact role of intravascular ultrasound in the achievement of these results needs to be established by appropriately designed studies. In the meantime, intravascular ultrasound coupled with the Palmaz-Schatz stent incorporating a spiral bridge, may have contributed considerably to the immediate angiographic outcome, which in turn may explain the favourable clinical and angiographic outcome at 6 months.
Peri-therapeutic multi-modal hemodynamic assessment and detection of predictors for symptomatic in-stent restenosis after percutaneous transluminal angioplasty and stenting

Xiaowen Song,Hancheng Qiu,Shuo Yang,Yuqi Liu,Yong Cao,Shuo Wang,Jizong Zhao

DOI: https://doi.org/10.3389/fneur.2023.1136847

2023-04-18

Abstract:Backgrounds: This study performed multi-modal hemodynamic analysis including quantitative color-coded digital subtraction angiography (QDSA) and computational fluid dynamics (CFD) to delineate peri-therapeutic hemodynamic changes and explore the risk factors for in-stent restenosis (ISR) and symptomatic ISR (sISR). Methods: Forty patients were retrospectively reviewed. Time to peak (TTP), full width at half maximum (FWHM), cerebral circulation time (CCT), angiographic mean transit time (aMTT), arterial stenosis index (ASI), wash-in gradient (WI), wash-out gradient (WO) and stasis index were calculated with QDSA and translesional pressure ratio (PR) and wall shear stress ratio (WSSR) were quantified from CFD analysis. These hemodynamic parameters were compared between before and after stent deployment and multivariate logistic regression model was established to detect predictors for ISR and sISR at follow-up. Results: It was found that stenting generally reduced TTP, stasis index, CCT, aMTT and translesional WSSR while significantly increased translesional PR. ASI decreased after stenting, and during the mean follow-up time of 6.48 ± 2.86 months, lower ASI (<0.636) as well as larger stasis index were corroborated to be independently associated with sISR. aMTT showed a linear correlation with CCT before and after stenting. Conclusion: PTAS not only improved cerebral circulation and blood flow perfusion but also changed local hemodynamics significantly. ASI and stasis index derived from QDSA were proved to play a prominent role in risk stratification for sISR. Multi-modal hemodynamic analysis could facilitate intraoperative real-time hemodynamic monitoring and help the determination of the end point of intervention.
In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial)

Iosif Xenogiannis,Bavana V Rangan,Lauren Uyeda,Subhash Banerjee,Robert Edson,Deepak L Bhatt,Steven Goldman,David R Holmes,Sunil V Rao,Kendrick Shunk,Kreton Mavromatis,Kodangudi Ramanathan,Antony A Bavry,Edward O McFalls,Santiago Garcia,Hoang Thai,Barry F Uretsky,Faisal Latif,Ehrin Armstrong,Jose Ortiz,Hani Jneid,Jayson Liu,Kul Aggrawal,Todd A Conner,Todd Wagner,Judit Karacsonyi,Beverly Ventura,Aaron Alsleben,Ying Lu,Mei-Chiung Shih,Emmanouil S Brilakis,Bavana V. Rangan,Deepak L. Bhatt,David R. Holmes,Sunil V. Rao,Antony A. Bavry,Edward O. McFalls,Barry F. Uretsky,Todd A. Conner,Emmanouil S. Brilakis

DOI: https://doi.org/10.1016/j.amjcard.2021.09.024

IF: 3.133

2022-01-01

The American Journal of Cardiology

Abstract:Saphenous vein grafts (SVGs) have high rates of in-stent restenosis (ISR). We compared the baseline clinical and angiographic characteristics of patients and lesions that did develop ISR with those who did not develop ISR during a median follow-up of 2.7 years in the DIVA study (NCT01121224). We also examined the ISR types using the Mehran classification. ISR developed in 119 out of the 575 DIVA patients (21%), with similar incidence among patients with drug-eluting stents and bare-metal stents (BMS) (21% vs 21%, p = 0.957). Patients in the ISR group were younger (67 ± 7 vs 69 ± 8 years, p = 0.04) and less likely to have heart failure (27% vs 38%, p = 0.03) and SVG lesions with Thrombolysis In Myocardial Infarction 3 flow before the intervention (77% vs 83%, p <0.01), but had a higher number of target SVG lesions (1.33 ± 0.64 vs 1.16 ± 0.42, p <0.01), more stents implanted in the target SVG lesions (1.52 ± 0.80 vs 1.31 ± 0.66, p <0.01), and longer total stent length (31.37 ± 22.11 vs 25.64 ± 17.42 mm, p = 0.01). The incidence of diffuse ISR was similar in patients who received drug-eluting-stents and BMS (57% vs 54%, p = 0.94), but BMS patients were more likely to develop occlusive restenosis (17% vs 33%, p = 0.05).

cardiac & cardiovascular systems
[Analysis of severe and threefold atypical and serious course of catatonic-paranoid psychosis].

T. Zyss,P. Franczuk,A. Potoczek,A. Zięba,D. Dudek,Z. Cwikliński,M. Rostworowska,W. Pieniażek,K. Rewiuk,T. Grodzicki,Magdalena Bosak,K. Banaszkiewicz,G. Zwolińska,A. Szczudlik

Psychiatria Polska

Abstract:The paper describes the difficult course of catatonic-paranoid psychosis which began with symptoms similar to the myasthenia. The growing symptoms of catatonia (in this oral mechanisms with the compulsion of mastication, injuring with teeth of the mouth, tongue biting and damage, such as lockjaw) brought about choking which was followed by aspiration pneumonia. The patient had to have pharmacological coma induced, along with muscle relaxation and artificial ventilation in the conditions of the intensive care department. Despite treatment with high doses of neuroleptics, the repeated trials of bringing the patient out from the coma caused recurrence of the catatonic symptoms. A decision was made to go along with electroconvulsive therapy. During one of the ECT treatments there were complications in the form of circulation cessation which required defibrillation. The paper contains basic information about the serious complications of the electroconvulsive therapy. It moreover carries out the critical analysis of the whole treatment period.
Current concepts of Parkinsonism.

J. Pearce,I. Pearce

DOI: https://doi.org/10.1136/pgmj.47.554.794

1971-12-01

Postgraduate Medical Journal

Abstract:THERE has been a striking renewal of interest in Parkinson's disease and related conditions in the last 10 years. Until this time, there was little treatment available which was really effective. As with many other chronic diseases of the nervous system, the condition was widely thought of as being progressive and incurable. The discovery of an abnormality in the dopamine content of the basal ganglia and the subsequent elucidation of levodopa and amantadine have revolutionized the treatment of the condition. Though the problems of Parkinson's disease are far from a complete solution, the importance of repeated clinical, pathological and histochemical investigation of hitherto obscure diseases of the nervous system is emphasized by the results obtained in this disease. A similar but earlier situation was seen in Wilson's disease where a fundamental biochemical anomaly was discovered, and a rational form of specific therapy was evolved.
Postfledging crèche behavior in the European shag

A. Velando

DOI: https://doi.org/10.1007/s101640170008

2001-12-01

Journal of Ethology

Abstract:
The mid-term effect of intravascular ultrasound on endovascular interventions for lower extremity peripheral arterial disease: A systematic review and meta-analysis

Junji Tsukagoshi,Tomonari Shimoda,Yujiro Yokoyama,Eric A Secemsky,Takuro Shirasu,Tatsuya Nakama,Kentaro Jujo,Jose Wiley,Hisato Takagi,Tadao Aikawa,Toshiki Kuno

DOI: https://doi.org/10.1016/j.jvs.2023.08.128

Abstract:Objective: Intravascular ultrasound (IVUS) is an important adjunctive tool for patients with lower extremity peripheral arterial disease (PAD) undergoing endovascular therapy (EVT). The evidence regarding the advantages of IVUS use is evolving, and recent studies have reported conflicting results. We aimed to perform a meta-analysis to evaluate the efficacy of IVUS during angiography-guided EVT for patients with PAD. Methods: MEDLINE and EMBASE were searched through April 2023 to identify studies that investigated the outcomes of IVUS with angiography-guided EVT vs angiography-alone-guided EVT. The primary outcome was restenosis/occlusion rate; secondary outcomes were target lesion revascularization, major amputation, and mortality. Results: One randomized controlled trial and 14 observational studies, largely of moderate quality, were included, yielding a total of 708,808 patients with 709,189 lesions that were treated with IVUS-guided EVT (n = 101,405) vs angiography-alone (n = 607,784). Compared with angiography alone, IVUS-guided EVT was associated with a non-significant trend towards decreased restenosis/occlusion (relative risk [RR], 0.74; 95% confidence interval [CI], 0.54-1.00; I2 = 60%). Although the risk of target lesion revascularization and mortality were comparable (RR, 0.85; 95% CI, 0.65-1.10; I2 = 70%; RR, 1.01; 95% CI, 0.79-1.28; I2 = 43%, respectively), the use of IVUS was also associated with significantly lower risk of major amputation (RR, 0.74; 95% CI, 0.67-0.82; I2 = 47%). Subgroup analysis focusing on femoropopliteal disease demonstrated significantly higher patency (RR, 0.72; 95% CI, 0.52-0.98; I2 = 73%). However, superiority with major amputation was not observed. Conclusions: IVUS-guided EVT for PAD may possibly be associated with a lower major amputation rate compared with angiography alone-guided EVT, although the difference in patency remained an insignificant trend in favor of IVUS-guided EVT. Adjunctive use of IVUS during EVT may be beneficial, and further prospective studies are warranted to delineate this relationship and the applicability of this technology in routine practice.
Clinical Outcome after Management of Unprotected Left Main In-Stent Restenosis after Bare Metal or Drug-Eluting Stents

Chen Shao-liang,Xu Bo,Gary Mintz,Ye Fei,Zhang Jun-jie,Kan Jing,Sun Xue-wen,Zhang Ai-ping,Chen Jin-guo,Qian Jun,Kwan W. Tak

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.2010.07.006

IF: 6.133

2010-01-01

Chinese Medical Journal

Abstract:BACKGROUND:Implantation of either bare metal stent (BMS) or drug-eluting stent (DES) has been used in every day practice for patients with unprotected left main stenosis (UPLMS). There are still a lack of data regarding the subsequent results of UPLMS in-stent restenosis (ISR). The present study aimed at determining the clinical outcome of UPLMS ISR patients after implantation of either BMS or DES.METHODS:Patients with UPLMS ISR after stenting were included. The primary endpoint was the cumulative major adverse cardiac events (MACE), including cardiac death, myocardial infarction (MI), and target vessel revascularization (TVR).RESULTS:UPLMS ISR rate was 14.8% (n = 73, 15.7% after BMS, 14.5% for DES) after average of (3.89 +/- 2.01) years (range from 1 to 10.5 years) follow-up. Angiographic follow-up between 6 - 8 months was available in 85.3%. Of these, repeat percutaneous coronary intervention (PCI) was used in 62 (84.9%) patients, with medicine only in 9 (12.4%) and coronary artery bypass graft (CABG) in 2 (2.7%). Most repeat PCI patients were with unstable angina (87.0%), and had decreased left ventricular ejection fraction ((42.58 +/- 5.12)%), fewer focal/ostial left circumflex branch (LCX) lesions, in relative to medicine only group. After (31.9 +/- 23.3) months, the MACE, MI, TVR and cardiac death were 31.5%, 1.4%, 24.1% and 8.2%, respectively. Definite and possible stent thrombosis occurred in 1 (1.4%) patient.CONCLUSIONS:Medical therapy for asymptomatic isolated ostial LCX was safe. Repeat PCI for UPLMS ISR was associated with acceptable early and short-term clinical outcome. Further study was needed to elucidate the role of CABG in treating UPLMS ISR.
[Artificial infant feeding in the area of the Canton Basel-City in the year 1957].

K. Baerlocher,H. Berger

Abstract:
ECG changes in prolonged treatment of kala-azar with antimony compounds.

A. Pandey,M. Kumar,C. P. Thakur

1988-06-01

Abstract:

Degeneracy, mimicry and crossreactivity in immune recognition.

Cementum status in natural teeth opposing implant-borne bridgework in Macaca fascicularis.

[CME-ORL. Cystic metastasis of a squamous epithelial carcinoma stage III on the right].

Physiology- or Imaging-Guided Strategies for Intermediate Coronary Stenosis.

Validation of the Global Anatomic Staging System (GLASS) Using the BASIL-1 Best Endovascular Therapy Cohort

Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor*

In-Stent Restenosis Progression in Human Superficial Femoral Arteries: Dynamics of Lumen Remodeling and Impact of Local Hemodynamics

Natural history of superior mesenteric artery in-stent restenosis

Society for Vascular Surgery duplex ultrasound surveillance guidelines are safe and cost effective for transcarotid artery revascularization

Oncogenic effect of repeated inoculation of mice with sheep erythrocytes.

Factors Influencing the Outcome of Symptomatic Intracranial Artery Stenosis With Hemodynamic Impairment After Short and Long-Term Stent Placement

Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study)

Peri-therapeutic multi-modal hemodynamic assessment and detection of predictors for symptomatic in-stent restenosis after percutaneous transluminal angioplasty and stenting

In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial)

[Analysis of severe and threefold atypical and serious course of catatonic-paranoid psychosis].

Current concepts of Parkinsonism.

Postfledging crèche behavior in the European shag

The mid-term effect of intravascular ultrasound on endovascular interventions for lower extremity peripheral arterial disease: A systematic review and meta-analysis

Clinical Outcome after Management of Unprotected Left Main In-Stent Restenosis after Bare Metal or Drug-Eluting Stents

[Artificial infant feeding in the area of the Canton Basel-City in the year 1957].

ECG changes in prolonged treatment of kala-azar with antimony compounds.